Type 2 Diabetes Clinical Trial Results

Browse clinical trials for Type 2 Diabetes by phase, sponsor and reported results. Data from ClinicalTrials.gov.

• Cardiovascular Outcomes in Bariatric Surgery Patients With Type 2 Diabetes
  N/A · The Cleveland Clinic · Completed · Aug 3, 2026
• Diabetes Prevention Program Outcomes Study
  Phase 3 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Completed · Oct 24, 2017
• Uric Acid Lowering Trial in Youth Onset T2D
  Phase 2 · University of Colorado, Denver · Completed · Jul 28, 2026
• Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM)-1
  N/A · State University of New York at Buffalo · Completed · Jul 24, 2026
• Continuous Glucose Monitoring Following Hospital Discharge
  N/A · Kathleen Dungan · Active, not recruiting · Dec 9, 2025
• Skeletal Muscle Diacylglycerol and Sphingolipids - Impact of Localization and Species on Insulin Resistance in
  N/A · University of Colorado, Denver · Completed · Jun 21, 2022
• A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus
  Phase 1 · Eli Lilly and Company · Completed · Jul 16, 2026
• A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is C
  Phase 2 · Bayer · Completed · Jul 13, 2026
• Diabetes Care for Breast Cancer Patients
  N/A · Weill Medical College of Cornell University · Completed · Jul 8, 2026
• A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants Wi
  Phase 3 · Eli Lilly and Company · Completed · Jul 8, 2026
• PROmoting Diabetes Education and Management Through Peer Support and Team Referral
  N/A · University of North Carolina, Chapel Hill · Completed · Jul 8, 2026
• Impact of Muscle and Tendon Dysfunction in People With Type 2 Diabetes Mellitus
  N/A · Universita di Verona · Completed · Jul 6, 2026
• A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Help
  Phase 3 · Novo Nordisk A/S · Completed · Jul 2, 2026
• A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
  Phase 3 · Eli Lilly and Company · Completed · Jun 30, 2026
• Diabetes Disparities: Texting to Extend Treatment (DD-TXT)
  N/A · VA Office of Research and Development · Completed · Jun 1, 2026

Trials by condition

Lung CancerNon-Small Cell Lung CancerBreast CancerColorectal CancerGastric CancerLiver CancerPancreatic CancerProstate CancerOvarian CancerMelanomaLeukemiaLymphomaMultiple MyelomaGlioblastomaType 2 DiabetesObesityHypertensionHeart FailureAtrial FibrillationStrokeChronic Kidney DiseaseNASH / MASHAlzheimer’s DiseaseParkinson’s DiseaseMultiple SclerosisDepressionEpilepsyALSRheumatoid ArthritisPsoriasisAtopic DermatitisCrohn’s DiseaseUlcerative ColitisLupusAsthmaCOPD

All trials